| 1 |
Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kitinhumangastrointestinalstromaltumors.Science,1998,279(5350):577-580.
|
| 2 |
Heinrich MC,Corless CL,Duensing A,et al.PDGFRA activating mutations in gastrointestinal stromal tumors.Science,2003,299(5607):708-710.
|
| 3 |
Hirota S,Isozaki K.Pathology of gastrointestinal stromal tumors.Pathol Int,2006,56(1):1-9.
|
| 4 |
贺慧颖,方伟岗,钟镐镐,等.165 例胃肠道间质瘤中c-kit 和PDGFRA 基因突变.中华病理学杂志,2006,35(5):262-266.
|
| 5 |
Kitamura Y,Hirota S,Nishida T.Gastrointestinal stromal tumors(GIST):a model for molecule-based diagnosis and treatment of solid tumors.Cancer Sci,2003,94(4):315-320.
|
| 6 |
Heinrich MC, Corless CL, Blanke CD, et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol, 2006, 24(29):4764-4774.
|
| 7 |
Rubin BP,Duensing A.Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors.Lab Invest,2006,86(10):981-986.
|
| 8 |
Debiec-Rychter M,Sciot R,Le Cesne A,et al.KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.Eur J Cancer,2006,42(8):1093-1103.
|
| 9 |
Lasota J,Wasag B,Steigen SE, et al. Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors.J Mol Diagn,2007,9(1):89-94.
|